Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 331
6
Diseases
101
Unique genes
0.183
Avg. similarity score
Congenital central hypoventilation syndrome
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Congenital central hypoventilation syndrome
Haddad syndrome
Central hypoventilation syndrome
Hirschsprung disease
central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease
Biliary atresia
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Congenital central hypoventilation syndrome | 5 | 5 | 9 |
| Haddad syndrome | 5 | 5 | 9 |
| Central hypoventilation syndrome | 4 | 4 | 3 |
| Hirschsprung disease | 4 | 4 | 67 |
| central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease | 4 | 4 | 1 |
| Biliary atresia | 2 | 2 | 31 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| PHOX2B | 5 / 6 | Central hypoventilation syndrome, central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease, Congenital central hypoventilation syndrome, Haddad syndrome and 1 more |
| EDN3 | 4 / 6 | Biliary atresia, Congenital central hypoventilation syndrome, Haddad syndrome, Hirschsprung disease |
| GDNF | 3 / 6 | Congenital central hypoventilation syndrome, Haddad syndrome, Hirschsprung disease |
| LBX1 | 3 / 6 | Central hypoventilation syndrome, Congenital central hypoventilation syndrome, Haddad syndrome |
| MYO1H | 3 / 6 | Central hypoventilation syndrome, Congenital central hypoventilation syndrome, Haddad syndrome |
| PAH | 3 / 6 | Biliary atresia, Congenital central hypoventilation syndrome, Haddad syndrome |
| RET | 3 / 6 | Congenital central hypoventilation syndrome, Haddad syndrome, Hirschsprung disease |
| ASCL1 | 2 / 6 | Congenital central hypoventilation syndrome, Haddad syndrome |
| BDNF | 2 / 6 | Congenital central hypoventilation syndrome, Haddad syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| ERBB2 Activates PTK6 Signaling | Reactome | 4 / 13 | 36.6× | 3.18e-6 | 1.30e-4 ✓ sig. |
| GRB7 events in ERBB2 signaling | Reactome | 3 / 5 | 71.3× | 5.70e-6 | 2.11e-4 ✓ sig. |
| ERBB2 Regulates Cell Motility | Reactome | 4 / 15 | 31.7× | 5.99e-6 | 2.20e-4 ✓ sig. |
| PI3K events in ERBB2 signaling | Reactome | 4 / 16 | 29.7× | 7.93e-6 | 2.76e-4 ✓ sig. |
| RAF/MAP kinase cascade | Reactome | 8 / 124 | 7.7× | 9.32e-6 | 3.16e-4 ✓ sig. |
| SHC1 events in ERBB2 signaling | Reactome | 4 / 17 | 28.0× | 1.03e-5 | 3.44e-4 ✓ sig. |
| Signaling by ERBB2 | Reactome | 4 / 18 | 26.4× | 1.32e-5 | 4.22e-4 ✓ sig. |
| Signaling by ERBB2 TMD/JMD mutants | Reactome | 4 / 22 | 21.6× | 3.07e-5 | 8.49e-4 ✓ sig. |
| Downregulation of ERBB2 signaling | Reactome | 4 / 24 | 19.8× | 4.40e-5 | 1.15e-3 ✓ sig. |
| Signaling by ERBB2 KD Mutants | Reactome | 4 / 25 | 19.0× | 5.20e-5 | 1.32e-3 ✓ sig. |
| Signaling by ERBB4 | Reactome | 3 / 11 | 32.4× | 9.07e-5 | 2.07e-3 ✓ sig. |
| Downregulation of ERBB2:ERBB3 signaling | Reactome | 3 / 13 | 27.4× | 1.55e-4 | 3.19e-3 ✓ sig. |
| GRB2 events in ERBB2 signaling | Reactome | 3 / 14 | 25.5× | 1.96e-4 | 3.85e-3 ✓ sig. |
| RET signaling | Reactome | 4 / 40 | 11.9× | 3.41e-4 | 5.93e-3 ✓ sig. |
| Constitutive Signaling by Aberrant PI3K in Cancer | Reactome | 5 / 75 | 7.9× | 4.12e-4 | 6.87e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| neural crest cell migration | GO:0001755 | 11 / 47 | 43.3× | 9.74e-16 | 7.57e-13 ✓ sig. |
| enteric nervous system development | GO:0048484 | 5 / 12 | 77.1× | 3.21e-9 | 6.27e-7 ✓ sig. |
| peripheral nervous system development | GO:0007422 | 6 / 26 | 42.7× | 4.52e-9 | 8.52e-7 ✓ sig. |
| neuron differentiation | GO:0030182 | 11 / 222 | 9.2× | 3.23e-8 | 4.68e-6 ✓ sig. |
| glial cell-derived neurotrophic factor receptor signaling pathway | GO:0035860 | 4 / 11 | 67.3× | 2.58e-7 | 2.68e-5 ✓ sig. |
| nervous system development | GO:0007399 | 16 / 631 | 4.7× | 2.63e-7 | 2.73e-5 ✓ sig. |
| cell development | GO:0048468 | 5 / 43 | 21.5× | 3.41e-6 | 2.21e-4 ✓ sig. |
| axon guidance | GO:0007411 | 8 / 192 | 7.7× | 9.59e-6 | 5.05e-4 ✓ sig. |
| ERBB2-ERBB3 signaling pathway | GO:0038133 | 3 / 9 | 61.7× | 1.26e-5 | 6.25e-4 ✓ sig. |
| cell population proliferation | GO:0008283 | 9 / 263 | 6.3× | 1.28e-5 | 6.32e-4 ✓ sig. |
| posterior midgut development | GO:0007497 | 2 / 2 | 185× | 2.89e-5 | 1.19e-3 ✓ sig. |
| cell surface receptor protein tyrosine kinase signaling pathway | GO:0007169 | 6 / 120 | 9.3× | 4.77e-5 | 1.73e-3 ✓ sig. |
| embryonic organ development | GO:0048568 | 4 / 42 | 17.6× | 7.68e-5 | 2.49e-3 ✓ sig. |
| sympathetic nervous system development | GO:0048485 | 3 / 17 | 32.7× | 9.86e-5 | 2.99e-3 ✓ sig. |
| oligodendrocyte differentiation | GO:0048709 | 4 / 45 | 16.4× | 1.01e-4 | 3.05e-3 ✓ sig. |